- Home
- DAIO vs SONN Comparison
DAIO vs SONN Comparison
Compare DAIO & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAIO
- SONN
- Stock Information
- Founded
- DAIO 1969
- SONN N/A
- Country
- DAIO United States
- SONN United States
- Employees
- DAIO N/A
- SONN N/A
- Industry
- DAIO Electrical Products
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- DAIO Industrials
- SONN Health Care
- Exchange
- DAIO Nasdaq
- SONN Nasdaq
- Market Cap
- DAIO 22.0M
- SONN 21.4M
- IPO Year
- DAIO N/A
- SONN N/A
- Fundamental
- Price
- DAIO $3.21
- SONN $2.85
- Analyst Decision
- DAIO Strong Buy
- SONN Strong Buy
- Analyst Count
- DAIO 1
- SONN 1
- Target Price
- DAIO $5.22
- SONN $20.00
- AVG Volume (30 Days)
- DAIO 43.4K
- SONN 563.6K
- Earning Date
- DAIO 10-23-2025
- SONN 08-13-2025
- Dividend Yield
- DAIO N/A
- SONN N/A
- EPS Growth
- DAIO N/A
- SONN N/A
- EPS
- DAIO N/A
- SONN N/A
- Revenue
- DAIO $22,732,000.00
- SONN $1,000,000.00
- Revenue This Year
- DAIO $9.52
- SONN $5,376.22
- Revenue Next Year
- DAIO $5.84
- SONN N/A
- P/E Ratio
- DAIO N/A
- SONN N/A
- Revenue Growth
- DAIO N/A
- SONN 1689.52
- 52 Week Low
- DAIO $1.88
- SONN $1.08
- 52 Week High
- DAIO $3.48
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- DAIO 52.95
- SONN 39.92
- Support Level
- DAIO $3.01
- SONN $3.02
- Resistance Level
- DAIO $3.27
- SONN $3.80
- Average True Range (ATR)
- DAIO 0.17
- SONN 0.31
- MACD
- DAIO -0.00
- SONN -0.04
- Stochastic Oscillator
- DAIO 78.38
- SONN 10.26
About DAIO Data I/O Corporation
Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.